LGRNX
Price
$26.24
Change
-$0.66 (-2.45%)
Updated
Sep 6 closing price
RGABX
Price
$64.26
Change
-$1.38 (-2.10%)
Updated
Sep 6 closing price
Ad is loading...

LGRNX vs RGABX

Header iconLGRNX vs RGABX Comparison
Open Charts LGRNX vs RGABXBanner chart's image
Loomis Sayles Growth N
Price$26.24
Change-$0.66 (-2.45%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2
Price$64.26
Change-$1.38 (-2.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LGRNX vs RGABX Comparison Chart
Loading...
VS
LGRNX vs. RGABX commentary
Sep 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRNX is a Buy and RGABX is a Buy.

FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 270B vs. LGRNX (13.7B). LGRNX (0.00) and RGABX (0.00) have matching dividends . LGRNX was incepted earlier than RGABX: LGRNX (12 years) vs RGABX (22 years). RGABX is a more actively managed with annual turnover of: 31.00 vs. LGRNX (13.00). RGABX has a lower initial minimum investment than LGRNX: RGABX (250) vs LGRNX (1000000). LGRNX (17.01) and RGABX (16.73) have marching annual gain over last year. LGRNX return over 5 years is better than : 54.25 vs. RGABX (39.81).
LGRNXRGABXLGRNX / RGABX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years22 years-
Gain YTD15.50014.976103%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.7B270B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.0116.73102%
Returns for 3 years-2.11-10.5220%
Returns for 5 years54.2539.81136%
Returns for 10 years169.3945.38373%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRDG8.090.12
+1.51%
Bridge Investment Group Holdings
IR87.610.35
+0.40%
Ingersoll Rand
TPCS3.310.01
+0.30%
TechPrecision Corp
ALEX19.35-0.05
-0.26%
Alexander & Baldwin
AXSM93.69-1.87
-1.96%
Axsome Therapeutics